| Dr David Nonesupplied Raimer, MD | |
|
1501 Broadway St, Galveston, TX 77550-4906 | |
| (409) 763-2452 | |
| (409) 763-2458 |
| Full Name | Dr David Nonesupplied Raimer |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 13 Years |
| Location | 1501 Broadway St, Galveston, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598956781 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Galveston Dermatology Pa | 2163464843 | 4 |
| Clear Lake Dermatology Pllc | 6800044181 | 5 |
News Archive
There is a wide variation in the use of laparoscopic surgery for gall bladder removal in Hong Kong hospitals, and use of this procedure is more likely at certain hospitals and among younger female patients operated on more recently, according to a study in the Archives of Surgery.
State leaders in Oregon, North Carolina and California consider new legislation or studies on what better mental health care for their residents could mean for quality of life and health care costs.
A computational tool developed at the University of Utah (U of U) has successfully identified diseases with unknown gene mutations in three separate cases, U of U researchers and their colleagues report in a new study in The American Journal of Human Genetics. The software, Phevor (Phenotype Driven Variant Ontological Re-ranking tool), identifies undiagnosed illnesses and unknown gene mutations by analyzing the exomes, or areas of DNA where proteins that code for genes are made, in individual patients and small families.
Groundbreaking research from UT Southwestern Medical Center shows that cholesterol efflux capacity (cholesterol efflux), which measures HDL cholesterol function, appears to be a superior indicator of cardiovascular risk and a better target for therapeutic treatments than standard measurements of HDL. Current measurement methods reflect only the circulating levels of HDL and not the functional properties of this lipoprotein.
Peptilogics, a development stage company utilizing its innovative peptide platform to treat multidrug-resistant bacterial infections, today announced it recently held a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration to discuss the regulatory pathway for the development of PLG0206 for the treatment of prosthetic joint infections.
› Verified 8 days ago
| Entity Name | Galveston Dermatology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104091487 PECOS PAC ID: 2163464843 Enrollment ID: O20071024000108 |
News Archive
There is a wide variation in the use of laparoscopic surgery for gall bladder removal in Hong Kong hospitals, and use of this procedure is more likely at certain hospitals and among younger female patients operated on more recently, according to a study in the Archives of Surgery.
State leaders in Oregon, North Carolina and California consider new legislation or studies on what better mental health care for their residents could mean for quality of life and health care costs.
A computational tool developed at the University of Utah (U of U) has successfully identified diseases with unknown gene mutations in three separate cases, U of U researchers and their colleagues report in a new study in The American Journal of Human Genetics. The software, Phevor (Phenotype Driven Variant Ontological Re-ranking tool), identifies undiagnosed illnesses and unknown gene mutations by analyzing the exomes, or areas of DNA where proteins that code for genes are made, in individual patients and small families.
Groundbreaking research from UT Southwestern Medical Center shows that cholesterol efflux capacity (cholesterol efflux), which measures HDL cholesterol function, appears to be a superior indicator of cardiovascular risk and a better target for therapeutic treatments than standard measurements of HDL. Current measurement methods reflect only the circulating levels of HDL and not the functional properties of this lipoprotein.
Peptilogics, a development stage company utilizing its innovative peptide platform to treat multidrug-resistant bacterial infections, today announced it recently held a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration to discuss the regulatory pathway for the development of PLG0206 for the treatment of prosthetic joint infections.
› Verified 8 days ago
| Entity Name | Clear Lake Dermatology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255686465 PECOS PAC ID: 6800044181 Enrollment ID: O20120911000359 |
News Archive
There is a wide variation in the use of laparoscopic surgery for gall bladder removal in Hong Kong hospitals, and use of this procedure is more likely at certain hospitals and among younger female patients operated on more recently, according to a study in the Archives of Surgery.
State leaders in Oregon, North Carolina and California consider new legislation or studies on what better mental health care for their residents could mean for quality of life and health care costs.
A computational tool developed at the University of Utah (U of U) has successfully identified diseases with unknown gene mutations in three separate cases, U of U researchers and their colleagues report in a new study in The American Journal of Human Genetics. The software, Phevor (Phenotype Driven Variant Ontological Re-ranking tool), identifies undiagnosed illnesses and unknown gene mutations by analyzing the exomes, or areas of DNA where proteins that code for genes are made, in individual patients and small families.
Groundbreaking research from UT Southwestern Medical Center shows that cholesterol efflux capacity (cholesterol efflux), which measures HDL cholesterol function, appears to be a superior indicator of cardiovascular risk and a better target for therapeutic treatments than standard measurements of HDL. Current measurement methods reflect only the circulating levels of HDL and not the functional properties of this lipoprotein.
Peptilogics, a development stage company utilizing its innovative peptide platform to treat multidrug-resistant bacterial infections, today announced it recently held a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration to discuss the regulatory pathway for the development of PLG0206 for the treatment of prosthetic joint infections.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Nonesupplied Raimer, MD 2900 Dominique Dr, Galveston, TX 77551-1571 Ph: () - | Dr David Nonesupplied Raimer, MD 1501 Broadway St, Galveston, TX 77550-4906 Ph: (409) 763-2452 |
News Archive
There is a wide variation in the use of laparoscopic surgery for gall bladder removal in Hong Kong hospitals, and use of this procedure is more likely at certain hospitals and among younger female patients operated on more recently, according to a study in the Archives of Surgery.
State leaders in Oregon, North Carolina and California consider new legislation or studies on what better mental health care for their residents could mean for quality of life and health care costs.
A computational tool developed at the University of Utah (U of U) has successfully identified diseases with unknown gene mutations in three separate cases, U of U researchers and their colleagues report in a new study in The American Journal of Human Genetics. The software, Phevor (Phenotype Driven Variant Ontological Re-ranking tool), identifies undiagnosed illnesses and unknown gene mutations by analyzing the exomes, or areas of DNA where proteins that code for genes are made, in individual patients and small families.
Groundbreaking research from UT Southwestern Medical Center shows that cholesterol efflux capacity (cholesterol efflux), which measures HDL cholesterol function, appears to be a superior indicator of cardiovascular risk and a better target for therapeutic treatments than standard measurements of HDL. Current measurement methods reflect only the circulating levels of HDL and not the functional properties of this lipoprotein.
Peptilogics, a development stage company utilizing its innovative peptide platform to treat multidrug-resistant bacterial infections, today announced it recently held a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration to discuss the regulatory pathway for the development of PLG0206 for the treatment of prosthetic joint infections.
› Verified 8 days ago
Frank Winsett, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1005 Harborside Dr 5th Floor, Galveston, TX 77555 Phone: 409-747-3376 Fax: 409-772-4456 | |
Dr. Ramon Larrea Sanchez, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1501 Broadway St, Galveston, TX 77550 Phone: 409-763-2452 Fax: 409-763-2458 | |
Michael George Wilkerson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 400 Harborside Dr, Galveston, TX 77555 Phone: 409-772-2222 | |
Janice May Wilson, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, University Of Texas Medical Branch-dermatology, Galveston, TX 77555 Phone: 409-772-1911 Fax: 409-772-4456 | |
Richard F Wagner Jr., MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 400 Harborside Dr, Galveston, TX 77555 Phone: 409-772-2222 | |
Lindy Ross, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-1911 | |
Dr. Erica B Kelly, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222 |